November 22, 2025
RA Jainee
SBI Healthcare Opportunities Fund details, NAV, Portfolio, Returns, Peer Comparison, Fund Managers & Guidance by sahifund.com
NAV Growth: Rs 494.7845
NAV IDCW: Rs 343.7619
Suitable For Which Investors?
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route.
Fund’s Investment Strategy:
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Fund Manager:
1) Tanmaya Desai
Education: Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).
Experience: Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.
Investment Details
| Min. Investment (₹) | 5,000 |
| Min. Addl Investment (₹) | 1,000 |
| Min. SIP Investment (₹) | 500 |
| Min. Withdrawal (₹) | 500 |
| Min. No of Cheques | 12 |
| Min. Balance (₹) | 1,000 |
| Lock-in Period | NA |
| Exit Load | 0.5% for redemption within 15 days |
Basic Details of SBI Healthcare Opportunities Fund
| Fund House | SBI Mutual Fund |
| Launch Date | 01-Jan-13 |
| Return Since Launch | 17.75% |
| Benchmark | BSE Healthcare TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | ₹ 4,082 Cr |
| (As on 31-Oct-2025) | |
| Expense | 0.91% |
| (As on 31-Oct-2025) | |
| Risk Grade | Low |
| Return Grade | Above Average |
| Turnover | 14.00% |
Trailing Returns (%)
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| SBI Healthcare Opportunities Dir | -0.50 | -0.33 | -2.22 | -1.28 | 3.16 | 4.99 | 25.61 | 20.42 | 20.94 | 12.68 |
| BSE Healthcare TRI | -1.41 | -0.50 | -2.26 | -0.79 | 4.62 | 5.18 | 24.67 | 18.32 | 18.22 | 11.12 |
| Equity: Sectoral-Pharma | -1.39 | -0.52 | -1.38 | -0.92 | 4.77 | 4.52 | 23.91 | 18.74 | 21.24 | 13.36 |
| Rank within category | 5 | 2 | 19 | 15 | 17 | 7 | 2 | 2 | 4 | 3 |
| Number of funds in category | 20 | 22 | 22 | 22 | 20 | 17 | 10 | 9 | 6 | 3 |
Peer Comparison of SBI Healthcare Opportunities Fund
| Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
| SBI Healthcare Opportunities Dir | 5 star | 4.99 | 25.61 | 20.42 | 0.91 | 4,082 | 17.75 | 0.50 (15) | 12Y 10M | 14.00 |
| ICICI Pru Pharma Healthcare and Diagnostics Dir | 5 star | 8.53 | 28.88 | 21.34 | 1.03 | 6,437 | 22.06 | 1.00 (15) | 7Y 4M | 61.00 |
| DSP Healthcare Dir | 4 star | -1.42 | 23.04 | 18.89 | 0.56 | 3,144 | 23.55 | 0.50 (30) | 6Y 11M | 9.00 |
| UTI Healthcare Dir | 4 star | 4.24 | 25.41 | 18.50 | 1.31 | 1,125 | 16.06 | 1.00 (30) | 12Y 10M | 31.00 |
| Nippon India Pharma Dir | 3 star | 3.82 | 23.03 | 18.71 | 0.89 | 8,346 | 17.77 | 1.00 (30) | 12Y 10M | 17.00 |
Portfolio Analysis of SBI Healthcare Opportunities Fund
| No. of Stocks | 29 |
| Top 10 Stocks | 50.38% |
| Top 5 Stocks | 32.51% |
| Top 3 Sectors | 96.05% |
| Portfolio P/B Ratio | 6.09 |
| Portfolio P/E Ratio | 48.75 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 65,143 | 79,618 |
| Giant (%) | 23.41 | 22.43 |
| Large (%) | 25.48 | 32.83 |
| Mid (%) | 40.58 | 38.41 |
| Small (%) | 10.53 | 12.00 |
| Tiny (%) | — | 0.10 |
Chanakya’s Mutual Fund Guidance For SBI Healthcare Opportunities Fund
WILL POST SOON
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully
Apply Online: https://online.sbimf.com/login
>> Post your MF questions @ sahifund.com/ask-me/
>> NFO Guidance:
https://sahifund.com/category/nfos/
Quicklinks
- Chanakyanipothi.com
- Staffavailable.com
- BigGaddi.com
- Latest IPO GMP
- Best Stocks to buy today
- Grey Market Premium
- Upcoming IPOs
- Subscription Status